Evidence map›Paper›PMID 35320456›Full record

ArticleMolecular neurobiology2022

Hyperammonemia Enhances GABAergic Neurotransmission in Hippocampus: Underlying Mechanisms and Modulation by Extracellular cGMP.

María Sancho-Alonso, Raquel Garcia-Garcia, Vicent Teruel-Martí, Marta Llansola, Vicente Felipo

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

María Sancho-AlonsoLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain.
Raquel Garcia-GarciaLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain.
Vicent Teruel-MartíAnatomy and Human Embryology Department, Faculty of Medicine, University of Valencia, 46010, Valencia, Spain.
Marta LlansolaLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain.
Vicente FelipoLaboratory of Neurobiology, Centro de Investigación Príncipe Felipe, 46012, Valencia, Spain. vfelipo@cipf.es.ORCID http://orcid.org/0000-0003-3145-9538
Centro de Investigacion Principe Felipe · ESUniversitat de València · ES

Funding

Conselleria d'Educació, Investigació, Cultura i Esport ACIF/2018/291Conselleria d'Educació, Investigació, Cultura i Esport PROMETEOII/2018/051European Regional Development Funds PID2019-108562GB-I00European Regional Development Funds PID2020-113388RB-I00European Regional Development Funds PROMETEOII/2018/051European Regional Development Funds SAF2017-82917-RMinisterio de Ciencia e Innovacion PID2019-108562GB-I00Ministerio de Ciencia e Innovación PID2020-113388RB-I00Ministerio de Ciencia e Innovación SAF2017-82917-R
6 · The paper itself

Abstract

Rats with chronic hyperammonemia reproduce the cognitive and motor impairment present in patients with hepatic encephalopathy. It has been proposed that enhanced GABAergic neurotransmission in hippocampus may contribute to impaired learning and memory in hyperammonemic rats. However, there are no direct evidences of the effects of hyperammonemia on GABAergic neurotransmission in hippocampus or on the underlying mechanisms. The aims of this work were to assess if chronic hyperammonemia enhances the function of GABA

Indexed as

Hepatic EncephalopathyHyperammonemiaAnimalsCyclic GMPGABA Plasma Membrane Transport Proteinsgamma-Aminobutyric AcidHippocampusHumansRatsRats, WistarReceptors, GABA-ASynaptic TransmissionCyclic GMPGABA Plasma Membrane Transport Proteinsgamma-Aminobutyric AcidReceptors, GABA-AGABAA receptorGABA transportersHippocampusHyperammonemiaInhibitory postsynaptic evoked potentials

Identifiers

PMID35320456
OpenAlexW4221004099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.